BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3108376)

  • 1. Synergistic effect of recombinant IL 2 and interferon-gamma on the proliferation of human monoclonal lymphocytes.
    Karray S; Vazquez A; Merle-Beral H; Olive D; Debre P; Galanaud P
    J Immunol; 1987 Jun; 138(11):3824-8. PubMed ID: 3108376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
    Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
    J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response.
    Karray S; Delfraissy JF; Merle-Beral H; Wallon C; Debre P; Galanaud P
    J Immunol; 1988 Feb; 140(3):774-8. PubMed ID: 3257503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
    Defrance T; Aubry JP; Vanbervliet B; Banchereau J
    J Immunol; 1986 Dec; 137(12):3861-7. PubMed ID: 3097134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
    Lasky JL; Thorbecke GJ
    Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
    Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
    Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor.
    Delfraissy JF; Wallon C; Vazquez A; Dugas B; Dormont J; Galanaud P
    Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T; Butler JL; Cooper MD
    J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12 stimulates B cell growth by inducing IFN-gamma.
    Li L; Young D; Wolf SF; Choi YS
    Cell Immunol; 1996 Mar; 168(2):133-40. PubMed ID: 8640858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between B cell differentiation factors and interleukin 2, using a monoclonal system.
    Mayer L; Crow MK; Thompson C
    J Immunol; 1985 Nov; 135(5):3272-6. PubMed ID: 2995489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A; GĂ©rard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
    Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12.
    Kohno K; Kataoka J; Ohtsuki T; Suemoto Y; Okamoto I; Usui M; Ikeda M; Kurimoto M
    J Immunol; 1997 Feb; 158(4):1541-50. PubMed ID: 9029088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT; Grant AJ; Siegel JP
    J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential synergistic effect of interleukin 2 and interferon-gamma on the differentiation of a Tac-antigen-positive B cell line.
    Nakagawa T; Nakagawa N; Volkman DJ; Fauci AS
    J Immunol; 1986 Jan; 136(1):164-8. PubMed ID: 2999242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.